Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking to your phone could detect diabetes, study finds

NCT ID NCT07421921

Diagnosis Sponsor: Thymia Limited Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether computer analysis of voice recordings can detect type 2 diabetes. Over 7,000 adults in the UK recorded themselves reading and answering questions online. A subset also provided blood samples to check accuracy. The goal is to see if voice biomarkers could become a simple, at-home screening tool for diabetes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple, non-invasive voice-based screening tool for type 2 diabetes, making early detection easier and more accessible.
What could go wrong
This is an early-stage observational study, not a treatment trial. The voice analysis may not be accurate enough for real-world screening, and results may not apply to non-English speakers or people outside the UK.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

7,319 people

The number who actually took part.

Started

Sep 2025

Finished

Mar 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of a convenience sample of UK-based adults recruited through Prolific, an established online research platform widely used in the UK by researchers. This remote recruitment enables access to a geographically dispersed population across the UK, including individuals with known diabetes and those unaware of their metabolic health status. The online methodology reaches populations who may not engage with traditional healthcare screening, where NHS Health Check attendance is only 40.4%. The study recruits 10,000 participants for initial voice analysis, capturing diverse demographic representation to ensure model applicability across different population groups. A strategically selected subset of 1,000 participants will receive HbA1c validation testing. Existing participants from thymia's research database who consented to recontact are also eligible, having completed similar voice protocols, enriching the dataset whilst reducing participant burden.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18+ years of age * English as a first language * No language difficulties * Geographically based in the UK * Normal or corrected to normal eye-sight, i.e., wearing glasses/contact lenses Exclusion Criteria: * No hearing impairments

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes (DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus glucose intolerance prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes (DM) T2DM T2DM (type 2 diabetes mellitus) Type 2 diabetes

Contacts and locations

Locations

  • Online

    Nationwide, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.